Download PDF
Exp Clin Endocrinol Diabetes 2019; 127(S 01): S1-S7
DOI: 10.1055/a-1018-9078
German Diabetes Association: Clinical Practice Guidelines
© Georg Thieme Verlag KG Stuttgart · New York

Definition, Classification and Diagnosis of Diabetes Mellitus[*]

Astrid Petersmann
1   Institute for Clinical Chemistry and Laboratory Medicine, University Medicine, Greifswald, Germany
2   Institute for Clinical Chemistry, University Medicine, Göttingen, Germany
,
Dirk Müller-Wieland
3   Medical Clinic I, RWTH Aachen University, Germany
,
Ulrich A. Müller
4   Clinic for Internal Medicine III, University Hospital Jena, Germany
,
Rüdiger Landgraf
5   German Diabetes Foundation (DDS), Düsseldorf, Germany
,
Matthias Nauck
1   Institute for Clinical Chemistry and Laboratory Medicine, University Medicine, Greifswald, Germany
6   DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, Greifswald, Germany, Germany
,
Guido Freckmann
7   Institute for Diabetes Technology, Forschungs- und Entwicklungsgesellschaft mbH at the University of Ulm, Germany
,
Lutz Heinemann
8   Science-Consulting in Diabetes GmbH (Science & Co), Neuss, Germany
,
Erwin Schleicher
9   Clinical Chemistry and Pathobiochemistry – Central Laboratory, University Hospital Tübingen, Germany
10   German Centre for Diabetes Research (DZD), Munich-Neuherberg, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
20 December 2019 (online)

Also available at
   Permissions and Reprints

Definition of Diabetes Mellitus

Diabetes mellitus is the collective term for heterogeneous metabolic disorders whose main finding is chronic hyperglycaemia. The cause is either a disturbed insulin secretion or a disturbed insulin effect or usually both.

* The team of authors has written the practical recommendation for the Commission for Laboratory Diagnostics in Diabetology/Kommission Labordiagnostik in der Diabetologie of the German Diabetes Society/Deutsche Diabetes Gesellschaft (DDG) and the German Society for Clinical Chemistry and Laboratory Medicine (DGKL)/ Deutschen Gesellschaft für Klinische Chemie und Laboratoriumsmedizin.


 

  • References

  • 1 Deutsche Diabetes Gesellschaft und Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, (Hrsg.) S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge. AWMF-Registernummer: 057-008. 2018; 2. Auflage https://www.awmf.org/uploads/tx_szleitlinien/ 057-008l_S3_Gestationsdiabetes-mellitus-GDM-Diagnostik-Therapie- Nachsorge_2019-06.pdf Stand: 14.08.2019
    PubMed
  • 2 Buzzetti R, Zampetti S, Maddaloni E. et al. Adult-onset autoimmune diabetes: Current knowledge and implications for management. Nat Rev Endocrinol 2017; 13: 674-686
    CrossrefPubMedGoogle Scholar
  • 3 Badenhoop K. MODY und andere monogenetische Diabetesformen. Diabetologe 2017; 13: 453-463
    CrossrefPubMedGoogle Scholar
  • 4 Bojunga J, Schlereth F. Type 3c diabetes mellitus-prevalence, diagnosis, special aspects of treatment. Diabetologe 2018; 14: 269-277
    CrossrefPubMedGoogle Scholar
  • 5 „Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratori- umsmedizinischer Untersuchungen“. Dtsch Arztebl International. 2013 110. 1822
    PubMedGoogle Scholar
  • 6 Masuch A. et al. Preventing misdiagnosis of diabetes in the elderly: Age- dependent HbA1c reference intervals derived from two population-ba- sed study cohorts. BMC Endocr Disord 2019; 19: 20
    CrossrefPubMedGoogle Scholar
  • 7 Ziegler AG. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013; 309: 2473-2479
    CrossrefPubMedGoogle Scholar
  • 8 Kufeldt J. et al. Prevalence and distribution of diabetes mellitus in a maximum care hospital: Urgent need for HbA1c-screening. Exp Clin Endocrinol Diabetes 2018; 126: 123-129
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Ahlqvist E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: A data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018; 6: 361-369
    CrossrefPubMedGoogle Scholar
  • 10 Zaharia OP. German Diabetes Study Group et al Risk of diabetes-asso- ciated diseases in subgroups of patients with recent-onset diabetes: A 5-year follow-up study. Lancet Diabetes Endocrinol. 2019 DOI: 10.1016/ S2213-8587(19)30187-1
    CrossrefPubMedGoogle Scholar
  • 11 Ziegler AG. et al. Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol. BMJ Open 2019; 9 (06) e028578 .
    CrossrefPubMedGoogle Scholar